Stock comparison
IDEXX LABORATORIES INC /DE is 20.4x more valuable than Intellia Therapeutics, Inc. by market capitalization ($44.06 B vs $2.16 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
IDXX is larger
IDEXX LABORATORIES INC /DE is 20.4x more valuable than Intellia Therapeutics, Inc. by market capitalization ($44.06 B vs $2.16 B).
Market value leader
IDXX
IDEXX LABORATORIES INC /DE is 20.4x more valuable than Intellia Therapeutics, Inc. by market capitalization ($44.06 B vs $2.16 B).
Revenue leader
IDXX
NTLA: $67.67M vs IDXX: $4.30B.
Profit leader
IDXX
NTLA: -$412.69M vs IDXX: $1.06B.
Margin leader
IDXX
NTLA: -609.9% vs IDXX: 24.6% net margin.
| Metric | NTLA | IDXX |
|---|---|---|
| Market cap | $2.16 B | $44.06 B |
| US-listed rank | #2076 | #358 |
| Revenue (latest FY) | $67.67M | $4.30B |
| Net income (latest FY) | -$412.69M | $1.06B |
| Net margin | -609.9% | 24.6% |
| P/E (trailing FY) | - | 41.6x |
| SEC filings | 679 | 2,148 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
IDEXX LABORATORIES INC /DE is 20.4x more valuable than Intellia Therapeutics, Inc. by market capitalization ($44.06 B vs $2.16 B).
In their latest fiscal years, Intellia Therapeutics, Inc. reported $67.67M in revenue while IDEXX LABORATORIES INC /DE reported $4.30B.
Full pages: Intellia Therapeutics, Inc. and IDEXX LABORATORIES INC /DE, or browse the full rankings.